Trusted Resources: Evidence & Education
Scientific literature and patient education texts
New Therapeutic Horizons for Graves’ Hyperthyroidism
source: Endocrine Reviews
authors: Laura C. Lane, Tim D. Cheetham, Petros Perros, Simon H S Pearcesummary/abstract:
Graves’ hyperthyroidism is characterized by the presence of autoantibodies that stimulate the thyroid-stimulating hormone receptor (TSHR), resulting in uncontrolled secretion of excessive thyroid hormone. Conventional treatments, including antithyroid medication, radioiodine, or surgery have remained largely unchanged for the past 70 years and either lack efficacy for many patients, or result in lifelong thyroid hormone replacement therapy, in the case of the latter 2 options. The demand for new therapeutic options, combined with greater insight into basic immunobiology, has led to the emergence of novel approaches to treat Graves’ hyperthyroidism. The current therapies under investigation include biologics, small molecules, and peptide immunomodulation.
There is a growing focus on TSHR-specific treatment modalities, which carry the advantage of eliciting a specific, targeted approach, with the aim of avoiding disruption of the functioning immune system. These therapies present a new opportunity to supersede the inadequate treatments currently available for some Graves’ patients, offering hope of successful restoration of euthyroidism without the need for ongoing therapy. Several of these therapeutic options have the potential to translate into clinical practice in the near future. This review provides a comprehensive summary of the recent advances and various stages of development of the novel therapeutic approaches to treat Graves’ hyperthyroidism.organization: Newcastle University, UK; Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK; The Great North Children’s Hospital, UK
Montefiore Medical Center Comprehensive Thyroid ProgramThe highly experienced physicians with t...
R. Patrick Yeatts, MDR. Patrick Yeatts, MD, is the Professor ...
Raymond Cho, MD, FACSRaymond Cho is Director of Ophthalmic Pl...
Treatment Options for Thyroid Eye or Graves’ Disease at Ohio Statehttps://www.youtube.com/watch?v=2vcbs9hu...
TED (Thyroid Eye Disease) – Lid Surgeryhttps://www.youtube.com/watch?v=n-xQy9wK...
Hyperthyroidism: Should I Use Antithyroid Medicine or Radioactive Iodine?You may want to have a say in this decis...
Clinical Outcomes of Graves’ Ophthalmopathy Treated with Intensity Modulated Radiation TherapyBackground: Radiation for Graves’ oph...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.